🎉 M&A multiples are live!
Check it out!

Stryker Valuation Multiples

Discover revenue and EBITDA valuation multiples for Stryker and similar public comparables like Myomo, InfuSystem, and SmartVest.

Stryker Overview

About Stryker

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.


Founded

1946

HQ

United States of America
Employees

53K+

Website

stryker.com

Financials

LTM Revenue $23.0B

LTM EBITDA $6.4B

EV

$150B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Stryker Financials

Stryker has a last 12-month revenue of $23.0B and a last 12-month EBITDA of $6.4B.

In the most recent fiscal year, Stryker achieved revenue of $22.6B and an EBITDA of $5.7B.

Stryker expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Stryker valuation multiples based on analyst estimates

Stryker P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $20.5B $22.6B XXX XXX XXX
Gross Profit $11.6B $13.1B XXX XXX XXX
Gross Margin 56% 58% XXX XXX XXX
EBITDA $4.9B $5.7B XXX XXX XXX
EBITDA Margin 24% 25% XXX XXX XXX
Net Profit $2.4B $3.2B XXX XXX XXX
Net Margin 12% 14% XXX XXX XXX
Net Debt $11.2B $10.0B XXX XXX XXX

Financial data powered by Morningstar, Inc.

Stryker Stock Performance

As of March 14, 2025, Stryker's stock price is $370.

Stryker has current market cap of $141B, and EV of $150B.

See Stryker trading valuation data

Stryker Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$150B $141B XXX XXX XXX XXX $12.45

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Stryker Valuation Multiples

As of March 14, 2025, Stryker has market cap of $141B and EV of $150B.

Stryker's trades at 6.5x LTM EV/Revenue multiple, and 23.6x LTM EBITDA.

Analysts estimate Stryker's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Stryker and 10K+ public comps

Stryker Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $150B XXX XXX XXX
EV/Revenue 6.6x XXX XXX XXX
EV/EBITDA 26.3x XXX XXX XXX
P/E 47.1x XXX XXX XXX
P/E/Growth 1.2x XXX XXX XXX
EV/FCF 43.0x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Stryker Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Stryker Valuation Multiples

Stryker's NTM/LTM revenue growth is 8%

Stryker's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, Stryker's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Stryker's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Stryker and other 10K+ public comps

Stryker Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 10% XXX XXX XXX XXX
EBITDA Margin 25% XXX XXX XXX XXX
EBITDA Growth 16% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 34% XXX XXX XXX XXX
Revenue per Employee $0.4M XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 6% XXX XXX XXX XXX
Opex to Revenue 43% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Stryker Public Comps

See public comps and valuation multiples for Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Stryker M&A and Investment Activity

Stryker acquired  XXX companies to date.

Last acquisition by Stryker was  XXXXXXXX, XXXXX XXXXX XXXXXX . Stryker acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Stryker

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Stryker

When was Stryker founded? Stryker was founded in 1946.
Where is Stryker headquartered? Stryker is headquartered in United States of America.
How many employees does Stryker have? As of today, Stryker has 53K+ employees.
Who is the CEO of Stryker? Stryker's CEO is Mr. Kevin A. Lobo.
Is Stryker publicy listed? Yes, Stryker is a public company listed on NYS.
What is the stock symbol of Stryker? Stryker trades under SYK ticker.
When did Stryker go public? Stryker went public in 1988.
Who are competitors of Stryker? Similar companies to Stryker include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of Stryker? Stryker's current market cap is $141B
What is the current revenue of Stryker? Stryker's last 12-month revenue is $23.0B.
What is the current EBITDA of Stryker? Stryker's last 12-month EBITDA is $6.4B.
What is the current EV/Revenue multiple of Stryker? Current revenue multiple of Stryker is 6.5x.
What is the current EV/EBITDA multiple of Stryker? Current EBITDA multiple of Stryker is 23.6x.
What is the current revenue growth of Stryker? Stryker revenue growth between 2023 and 2024 was 10%.
Is Stryker profitable? Yes, Stryker is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.